MONSPHERE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MONSPHERE Trademark

Serial Number: 79358521 • Registration: 7227089

MONSPHERE is a trademark filed by ECZACIBASI MONROL NÜKLEER ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI on February 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

ECZACIBASI MONROL NÜKLEER ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI

BARIS M TÜBITAK MAM TEK BÖL GES Gebze

Entity Type: 03

Trademark Details

Filing Date

February 10, 2022

Registration Date

November 28, 2023

Published for Opposition

September 12, 2023

Goods & Services

Pharmaceuticals preparations for the treatment and prevention of cancer; Medical preparations for the treatment of cancer and cancerous tumors; Veterinary preparations for cancer and cancerous tumors for animals; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer for medical and veterinary purposes; Ginseng capsules for medical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for the diagnosis of pregnancy for medical and pharmaceutical purposes; chemical preparations for sanitary purposes for veterinary purposes; chemicopharmaceutical preparations for the treatment of cancer; Drug delivery agents in the form of beads, pills, liquid, capsules, dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of a coating for drug and pharmaceuticals preparations that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of circulatory diseases; pharmaceutical preparations for embolization for the treatment of blood vessels; pharmaceutical preparations for embolization of tumours and arteriovenous malformations (AVMs) for the treatment of circulatory conditions; pharmaceutical preparations for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medical purposes, vaccine adjuvants and adjuvants for use with vaccines; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations for the treatment of the circulatory system, vaccines and Antitoxic sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; diagnostic preparations for medical purposes; radioactive substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer; radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; pharmaceutical preparations in the form of particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; pharmaceutical preparations in the form of microcapsules and microparticles adapted to selectively deliver radioactivity to a target for the treatment of cancer; pharmaceutical preparations in the form of microscopic particles and microcapsules for the treatment of cancer and other diseased cells; pharmaceutical preparations in the form of microscopic particles adapted to selectively deliver radioactive material to a target site such as a cell or organ for the treatment of cancer

Surgical and medical apparatus and instruments for the treatment of cancer, radiological apparatus for medical purposes, radiology screens for medical purposes, namely, radiation shields for protection against X-rays for medical purposes; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body for the treatment of cancer; drug delivery embolisation apparatus, instruments and systems; medical apparatus and instruments for embolisation for the treatment of cancer; beads, impregnated with radioactive material or radioactive pharmaceutical preparations; microscopic glass beads being medical devices impregnated with radioactive material or radioactive pharmaceutical preparations and administered surgically for treatment of cancerous tumors; glass beads being medical devices containing radioactive material for the treatment of cancerous tumors; glass beads being medical devices containing radioactive pharmaceutical preparations for the treatment of cancerous tumors; implantable radiation therapy devices consisting of radioactive beads, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads for treatment of cancerous tumours; radioactive beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours; medical device, apparatus and instruments for treating cancer; Surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments, namely, a drug delivery system comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation for the treatment of cancer; surgical and medical apparatus and instruments for use in the circulatory system for the treatment of cancer; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues for the treatment of cancer; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment for the treatment of cancer; surgical and medical devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles for treating cancer; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating for treating cancer; medical devices for ablating human and animal tissue using microwave energy for treating cancer; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts thereforfor all the aforesaid goods; medical apparatus and instruments, namely, beads impregnated with radioactive material for treatment of cancerous tumors, beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumours, beads containing radioactive material, glass beads containing radioactive pharmaceutical preparations, and microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumors, beads in the nature of microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumours

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 8, 2024 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 2, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 1, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 28, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Sep 25, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 12, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 1, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 30, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 23, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2023 CNSA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 28, 2023 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2023 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 31, 2022 MAFR
ASSIGNED TO EXAMINER
Dec 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 23, 2022 REPR